{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T04:26:12Z","timestamp":1648527972205},"reference-count":46,"publisher":"Bentham Science Publishers Ltd.","issue":"17","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2020,6,4]]},"abstract":"<jats:sec>\n<jats:title \/>\n<jats:p>Diagnosis of vasculitis is based on the presence of histologic features and serological testing\nfor antineutrophil cytoplasmic antibodies (ANCA). In patients with vasculitis, two types of ANCA have\nbeen identified: ANCA directed against the neutrophil serine protease proteinase-3 (PR3) which results\nin a cytoplasmic immunofluorescence pattern (c-ANCA) and ANCA directed against the neutrophil enzyme\nmyeloperoxidase (MPO), which results in a perinuclear immunofluorescence pattern (p-ANCA).\nQuestion is if the presence of ANCA is the consequence of abnormal neutrophil adhesion, activation,\nand apoptosis. Or is it, through mechanisms which are not totally clear for the moment, the cause of vasculitis.\nIn the latter case it has to be postulated that ANCA autoantigens are expressed on the cell surface\nof viable, or activated, or early-apoptotic neutrophils.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867327666191213112220","type":"journal-article","created":{"date-parts":[[2019,12,16]],"date-time":"2019-12-16T09:48:04Z","timestamp":1576489684000},"page":"2852-2862","update-policy":"http:\/\/dx.doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Saint John on Patmos: Revelations of the Role of Antineutrophil Cytoplasmic Antibody (ANCA) in Vasculitis"],"prefix":"10.2174","volume":"27","author":[{"given":"Esther N.","family":"Pijnappel","sequence":"first","affiliation":[{"name":"Department. of Science, University College Roosevelt, Middelburg, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ger T.","family":"Rijkers","sequence":"additional","affiliation":[{"name":"Department. of Science, University College Roosevelt, Middelburg, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frans J. van","family":"Overveld","sequence":"additional","affiliation":[{"name":"Department. of Science, University College Roosevelt, Middelburg, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","first-page":"315","volume":"27","author":"Cupps T.R.","year":"1982","unstructured":"Cupps T.R.; Fauci A.S.; The vasculitic syndromes. Adv Intern Med 1982,27,315-344","journal-title":"Adv Intern Med"},{"key":"ref=2","author":"Collins T.R.","year":"2016","unstructured":"Collins T.R.;  Diagnostic criteria, classification lacking for vasculitis; new research in treatment for systemic sclerosis 2016","journal-title":"Diagnostic criteria, classification lacking for vasculitis; new research in treatment for systemic sclerosis"},{"key":"ref=3","author":"Freeman S.","year":"2017","unstructured":"Freeman S.;  New ACR-EULAR diagnostic criteria proposed for ANCA-associated vasculitides 2017","journal-title":"New ACR-EULAR diagnostic criteria proposed for ANCA-associated vasculitides"},{"key":"ref=4","author":"Luqmani P.M.","year":"2016","unstructured":"Luqmani P.M.; Watts R.;   New classification criteria for ANCA-associated vasculitis: implications for clinical practice, ACR\/ARHP Annual Meeting, Washington, DC, USA, November2016","journal-title":""},{"key":"ref=5","year":"2018","unstructured":"DCVAS Diagnostic and classification of the systemic vasculitides 2018","journal-title":"DCVAS Diagnostic and classification of the systemic vasculitides"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/nrrheum.2017.140","volume":"13","author":"Bossuyt X.","year":"2017","unstructured":"Bossuyt X.; Cohen Tervaert J.W.; Arimura Y.; Blockmans D.; Flores-Su\u00e1rez L.F.; Guillevin L.; Hellmich B.; Jayne D.; Jennette J.C.; Kallenberg C.G.M.; Moiseev S.; Novikov P.; Radice A.; Savige J.A.; Sinico R.A.; Specks U.; van Paassen P.; Zhao M.H.; Rasmussen N.; Damoiseaux J.; Csernok E.; Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol 2017,13(11),683-692","journal-title":"Nat Rev Rheumatol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/ki.1990.48","volume":"37","author":"Tervaert J.W.","year":"1990","unstructured":"Tervaert J.W.; Goldschmeding R.; Elema J.D.; van der Giessen M.; Huitema M.G.; van der Hem G.K.; The T.H.; von dem Borne A.E.; Kallenberg C.G.; Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis. Kidney Int 1990,37(2),799-806","journal-title":"Kidney Int"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1001\/archinte.1989.00390110055012","volume":"149","author":"Tervaert J.W.","year":"1989","unstructured":"Tervaert J.W.; van der Woude F.J.; Fauci A.S.; Ambrus J.L.; Velosa J.; Keane W.F.; Meijer S.; van der Giessen M.; van der Hem G.K.; The T.H.; Association between active Wegener\u2019s granulomatosis and anticytoplasmic antibodies. Arch Intern Med 1989,149(11),2461-2465","journal-title":"Arch Intern Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1046\/j.1523-1755.2000.057003846.x","volume":"57","author":"Savige J.","year":"2000","unstructured":"Savige J.; Davies D.; Falk R.J.; Jennette J.C.; Wiik A.; Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int 2000,57(3),846-862","journal-title":"Kidney Int"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.4049\/jimmunol.1200600","volume":"189","author":"Gabillet J.","year":"2012","unstructured":"Gabillet J.; Millet A.; Pederzoli-Ribeil M.; Tacnet-Delorme P.; Guillevin L.; Mouthon L.; Frachet P.; Witko-Sarsat V.; Proteinase 3, the autoantigen in granulomatosis with polyangiitis, associates with calreticulin on apoptotic neutrophils, impairs macrophage phagocytosis, and promotes inflammation. J Immunol 2012,189(5),2574-2583","journal-title":"J Immunol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.4049\/jimmunol.1102540","volume":"188","author":"Kuckleburg C.J.","year":"2012","unstructured":"Kuckleburg C.J.; Tilkens S.B.; Santoso S.; Newman P.J.; Proteinase 3 contributes to transendothelial migration of NB1-positive neutrophils. J Immunol 2012,188(5),2419-2426","journal-title":"J Immunol"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/j.1365-2249.2008.03663.x","volume":"152","author":"von Vietinghoff S.","year":"2008","unstructured":"von Vietinghoff S.; Eulenberg C.; Wellner M.; Luft F.C.; Kettritz R.; Neutrophil surface presentation of the anti-neutrophil cytoplasmic antibody-antigen proteinase 3 depends on N-terminal processing. Clin Exp Immunol 2008,152(3),508-516","journal-title":"Clin Exp Immunol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"4086","DOI":"10.1182\/blood-2007-03-080457","volume":"110","author":"Kantari C.","year":"2007","unstructured":"Kantari C.; Pederzoli-Ribeil M.; Amir-Moazami O.; Gausson-Dorey V.; Moura I.C.; Lecomte M.C.; Benhamou M.; Witko-Sarsat V.; Proteinase 3, the Wegener autoantigen, is externalized during neutrophil apoptosis: evidence for a functional association with phospholipid scramblase 1 and interference with macrophage phagocytosis. Blood 2007,110(12),4086-4095","journal-title":"Blood"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.cell.2005.08.032","volume":"123","author":"Gardai S.J.","year":"2005","unstructured":"Gardai S.J.; McPhillips K.A.; Frasch S.C.; Janssen W.J.; Starefeldt A.; Murphy-Ullrich J.E.; Bratton D.L.; Oldenborg P.A.; Michalak M.; Henson P.M.; Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte. Cell 2005,123(2),321-334","journal-title":"Cell"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1126\/science.1252809","volume":"344","author":"Segawa K.","year":"2014","unstructured":"Segawa K.; Kurata S.; Yanagihashi Y.; Brummelkamp T.R.; Matsuda F.; Nagata S.; Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure. Science 2014,344(6188),1164-1168","journal-title":"Science"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0163-7827(03)00025-0","volume":"42","author":"Lentz B.R.","year":"2003","unstructured":"Lentz B.R.; Exposure of platelet membrane phosphatidylserine regulates blood coagulation. Prog Lipid Res 2003,42(5),423-438","journal-title":"Prog Lipid Res"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1096\/fj.09-145482","volume":"24","author":"Gold L.I.","year":"2010","unstructured":"Gold L.I.; Eggleton P.; Sweetwyne M.T.; Van Duyn L.B.; Greives M.R.; Naylor S.M.; Michalak M.; Murphy-Ullrich J.E.; Calreticulin: non-endoplasmic reticulum functions in physiology and disease. FASEB J 2010,24(3),665-683","journal-title":"FASEB J"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1042\/BJ20081847","volume":"417","author":"Michalak M.","year":"2009","unstructured":"Michalak M.; Groenendyk J.; Szabo E.; Gold L.I.; Opas M.; Calreticulin, a multi-process calcium-buffering chaperone of the endoplasmic reticulum. Biochem J 2009,417(3),651-666","journal-title":"Biochem J"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1172\/JCI113970","volume":"83","author":"Savill J.S.","year":"1989","unstructured":"Savill J.S.; Wyllie A.H.; Henson J.E.; Walport M.J.; Henson P.M.; Haslett C.; Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989,83(3),865-875","journal-title":"J Clin Invest"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1073\/pnas.0511206103","volume":"103","author":"Novick D.","year":"2006","unstructured":"Novick D.; Rubinstein M.; Azam T.; Rabinkov A.; Dinarello C.A.; Kim S.H.; Proteinase 3 is an IL-32 binding protein. Proc Natl Acad Sci USA 2006,103(9),3316-3321","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1093\/rheumatology\/kes163","volume":"51","author":"Bae S.","year":"2012","unstructured":"Bae S.; Kim Y.G.; Choi J.; Hong J.; Lee S.; Kang T.; Jeon H.; Hong K.; Kim E.; Kwak A.; Lee C.K.; Yoo B.; Park Y.B.; Song E.Y.; Kim S.; Elevated interleukin-32 expression in granulomatosis with polyangiitis. Rheumatology (Oxford) 2012,51(11),1979-1988","journal-title":"Rheumatology (Oxford)"},{"key":"ref=22","first-page":"4726","volume":"9","author":"Khawar M.B.","year":"2017","unstructured":"Khawar M.B.; Mukhtar M.; Abbasi M.H.; Sheikh N.; IL-32\u03b8: a recently identified anti-inflammatory variant of IL-32 and its preventive role in various disorders and tumor suppressor activity. Am J Transl Res 2017,9(11),4726-4737","journal-title":"Am J Transl Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.7150\/thno.18407","volume":"7","author":"Son D.J.","year":"2017","unstructured":"Son D.J.; Jung Y.Y.; Seo Y.S.; Park H.; Lee D.H.; Kim S.; Roh Y.S.; Han S.B.; Yoon D.Y.; Hong J.T.; Interleukin-32alpha inhibits endothelial inflammation, vascular smooth muscle cell activation, and atherosclerosis by upregulating Timp3 and Reck through suppressing microRNA-205 biogenesis. Theranostics 2017,7(8),2186-2203","journal-title":"Theranostics"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s00281-013-0362-z","volume":"35","author":"Korkmaz B.","year":"2013","unstructured":"Korkmaz B.; Lesner A.; Letast S.; Mahdi Y.K.; Jourdan M.L.; Dallet-Choisy S.; Marchand-Adam S.; Kellenberger C.; Viaud-Massuard M.C.; Jenne D.E.; Gauthier F.; Neutrophil proteinase 3 and dipeptidyl peptidase I (cathepsin C) as pharmacological targets in granulomatosis with polyangiitis (Wegener granulomatosis). Semin Immunopathol 2013,35(4),411-421","journal-title":"Semin Immunopathol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"6570","DOI":"10.1093\/emboj\/20.23.6570","volume":"20","author":"Turk D.","year":"2001","unstructured":"Turk D.; Janji\u0107 V.; Stern I.; Podobnik M.; Lamba D.; Dahl S.W.; Lauritzen C.; Pedersen J.; Turk V.; Turk B.; Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases. EMBO J 2001,20(23),6570-6582","journal-title":"EMBO J"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"8215","DOI":"10.1073\/pnas.89.17.8215","volume":"89","author":"Zimmer M.","year":"1992","unstructured":"Zimmer M.; Medcalf R.L.; Fink T.M.; Mattmann C.; Lichter P.; Jenne D.E.; Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter. Proc Natl Acad Sci USA 1992,89(17),8215-8219","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=27","first-page":"38","volume":"90","author":"Garwicz D.","year":"2005","unstructured":"Garwicz D.; Lennartsson A.; Jacobsen S.E.; Gullberg U.; Lindmark A.; Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model. Haematologica 2005,90(1),38-44","journal-title":"Haematologica"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1074\/jbc.271.6.2972","volume":"271","author":"Rao N.V.","year":"1996","unstructured":"Rao N.V.; Rao G.V.; Marshall B.C.; Hoidal J.R.; Biosynthesis and processing of proteinase 3 in U937 cells. Processing pathways are distinct from those of cathepsin G. J Biol Chem 1996,271(6),2972-2978","journal-title":"J Biol Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1177\/1076029607303961","volume":"14","author":"Matsumoto T.","year":"2008","unstructured":"Matsumoto T.; Kaneko T.; Seto M.; Wada H.; Kobayashi T.; Nakatani K.; Tonomura H.; Tono Y.; Ohyabu M.; Nobori T.; Shiku H.; Sudo A.; Uchida A.; Kurosawa D.J.; Kurosawa S.; The membrane proteinase 3 expression on neutrophils was downregulated after treatment with infliximab in patients with rheumatoid arthritis. Clin Appl Thromb Hemost 2008,14(2),186-192","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","volume":"75","author":"Yates M.","year":"2016","unstructured":"Yates M.; Watts R.A.; Bajema I.M.; Cid M.C.; Crestani B.; Hauser T.; Hellmich B.; Holle J.U.; Laudien M.; Little M.A.; Luqmani R.A.; Mahr A.; Merkel P.A.; Mills J.; Mooney J.; Segelmark M.; Tesar V.; Westman K.; Vaglio A.; Yal\u00e7\u0131nda\u011f N.; Jayne D.R.; Mukhtyar C.; EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheum Dis 2016,75(9),1583-1594","journal-title":"Ann Rheum Dis"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"4115","DOI":"10.1073\/pnas.87.11.4115","volume":"87","author":"Falk R.J.","year":"1990","unstructured":"Falk R.J.; Terrell R.S.; Charles L.A.; Jennette J.C.; Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990,87(11),4115-4119","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1172\/JCI119662","volume":"100","author":"Ralston D.R.","year":"1997","unstructured":"Ralston D.R.; Marsh C.B.; Lowe M.P.; Wewers M.D.; Antineutrophil cytoplasmic antibodies induce monocyte IL-8 release. Role of surface proteinase-3, alpha1-antitrypsin, and Fcgamma receptors. J Clin Invest 1997,100(6),1416-1424","journal-title":"J Clin Invest"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1084\/jem.169.3.1071","volume":"169","author":"Remold-O\u2019Donnell E.","year":"1989","unstructured":"Remold-O\u2019Donnell E.; Nixon J.C.; Rose R.M.; Elastase inhibitor. Characterization of the human elastase inhibitor molecule associated with monocytes, macrophages, and neutrophils. J Exp Med 1989,169(3),1071-1086","journal-title":"J Exp Med"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"15762","DOI":"10.1021\/bi0113925","volume":"40","author":"Cooley J.","year":"2001","unstructured":"Cooley J.; Takayama T.K.; Shapiro S.D.; Schechter N.M.; Remold-O\u2019Donnell E.; The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Biochemistry 2001,40(51),15762-15770","journal-title":"Biochemistry"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1097\/01.ASN.0000040751.83734.D1","volume":"14","author":"Schreiber A.","year":"2003","unstructured":"Schreiber A.; Busjahn A.; Luft F.C.; Kettritz R.; Membrane expression of proteinase 3 is genetically determined. J Am Soc Nephrol 2003,14(1),68-75","journal-title":"J Am Soc Nephrol"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00281-014-0436-6","volume":"36","author":"McKinney E.F.","year":"2014","unstructured":"McKinney E.F.; Willcocks L.C.; Broecker V.; Smith K.G.; The immunopathology of ANCA-associated vasculitis. Semin Immunopathol 2014,36(4),461-478","journal-title":"Semin Immunopathol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1056\/NEJMoa1108735","volume":"367","author":"Lyons P.A.","year":"2012","unstructured":"Lyons P.A.; Rayner T.F.; Trivedi S.; Holle J.U.; Watts R.A.; Jayne D.R.; Baslund B.; Brenchley P.; Bruchfeld A.; Chaudhry A.N.; Cohen Tervaert J.W.; Deloukas P.; Feighery C.; Gross W.L.; Guillevin L.; Gunnarsson I.; Harper L.; Hru\u0161kov\u00e1 Z.; Little M.A.; Martorana D.; Neumann T.; Ohlsson S.; Padmanabhan S.; Pusey C.D.; Salama A.D.; Sanders J.S.; Savage C.O.; Segelmark M.; Stegeman C.A.; Tesa\u0159 V.; Vaglio A.; Wieczorek S.; Wilde B.; Zwerina J.; Rees A.J.; Clayton D.G.; Smith K.G.; Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012,367(3),214-223","journal-title":"N Engl J Med"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"242","DOI":"10.3109\/03009742.2013.846405","volume":"43","author":"Mohammad A.","year":"2014","unstructured":"Mohammad A.; Segelmark M.; Primary systemic vasculitis with severe \u03b11-antitrypsin deficiency revisited. Scand J Rheumatol 2014,43(3),242-245","journal-title":"Scand J Rheumatol"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/8140641","volume":"2017","author":"Voorzaat B.M.","year":"2017","unstructured":"Voorzaat B.M.; van Schaik J.; Crobach S.L.; van Rijswijk C.S.; Rotmans J.I.; Alpha-1 antitrypsin deficiency presenting with MPO-ANCA associated vasculitis and aortic dissection. Case Rep Med 2017,2017","journal-title":"Case Rep Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1165\/ajrcmb.24.6.4147","volume":"24","author":"Rooney C.P.","year":"2001","unstructured":"Rooney C.P.; Taggart C.; Coakley R.; McElvaney N.G.; O\u2019Neill S.J.; Anti-proteinase 3 antibody activation of neutrophils can be inhibited by alpha1-antitrypsin. Am J Respir Cell Mol Biol 2001,24(6),747-754","journal-title":"Am J Respir Cell Mol Biol"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.pharep.2016.08.003","volume":"68","author":"Surmiak M.","year":"2016","unstructured":"Surmiak M.; Sanak M.; Different forms of alpha-1 antitrypsin and neutrophil activation mediated by human anti-PR3 IgG antibodies. Pharmacol Rep 2016,68(6),1276-1284","journal-title":"Pharmacol Rep"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00296-013-2745-9","volume":"34","author":"Mota A.","year":"2014","unstructured":"Mota A.; Sahebghadam Lotfi A.; Jamshidi A.R.; Najavand S.; Alpha 1-antitrypsin activity is markedly decreased in Wegener\u2019s granulomatosis. Rheumatol Int 2014,34(4),553-558","journal-title":"Rheumatol Int"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1365-2249.2011.04355.x","volume":"164","author":"Kallenberg C.G.","year":"2011","unstructured":"Kallenberg C.G.; Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis: where to go? Clin Exp Immunol 2011,164(Suppl. 1),1-3","journal-title":"Clin Exp Immunol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/nm.1874","volume":"14","author":"Kain R.","year":"2008","unstructured":"Kain R.; Exner M.; Brandes R.; Ziebermayr R.; Cunningham D.; Alderson C.A.; Davidovits A.; Raab I.; Jahn R.; Ashour O.; Spitzauer S.; Sunder-Plassmann G.; Fukuda M.; Klemm P.; Rees A.J.; Kerjaschki D.; Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis. Nat Med 2008,14(10),1088-1096","journal-title":"Nat Med"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/ar392","volume":"4","author":"Popa E.R.","year":"2002","unstructured":"Popa E.R.; Stegeman C.A.; Kallenberg C.G.; Tervaert J.W.; \n                        Staphylococcus aureus and Wegener\u2019s granulomatosis. Arthritis Res 2002,4(2),77-79","journal-title":"Arthritis Res"},{"key":"ref=46","author":"Bonert M.","year":"2019.","unstructured":"Bonert M.; File: Wegener's granulomatosis - very high\nmag.jpg. Available at: (Accessed Date: November 2019).2019."}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/177435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T03:16:00Z","timestamp":1594955760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/177435\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,4]]},"references-count":46,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2020,6,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867327666191213112220","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-03-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-08","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}